High materiality8/10
Assembly Biosciences price target raised to $45 from $40 at Mizuho
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho Securities raises ASMB target to $45 from $40. Current price around $22.96; indicates substantial upside potential.
- ASMB target raised to $45; price $22.96; substantial upside.
Key facts
- 01
Target: $45
- 02
Posted price: $22.96
- 03
Analyst firm: Mizuho Securities
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.